SCHEMBL6360109

SCHEMBL6360109

CCCCCNC(=O)N(CCc1cccc(O[C@](C)(CC)C(=O)O)c1)CCc1ccc(F)cc1F

nearest known ligand 0.61

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 10/20 0.61
PPARG P37231 9/20 0.61
PPARD Q03181 2/20 0.45
CYP2D6 P10635 2/20 0.39
FDFT1 P37268 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6363503 1.00 PPARA (0.61) PPARAPPARGPPARDCYP2D6FDFT1
SCHEMBL6358999 1.00 PPARA (0.61) PPARAPPARGPPARDCYP2D6FDFT1
SCHEMBL6363301 0.99 PPARA (0.62) PPARAPPARGPPARDCYP2D6
SCHEMBL6359234 0.99 PPARA (0.62) PPARAPPARGPPARDCYP2D6
SCHEMBL6363262 0.99 PPARA (0.62) PPARAPPARGPPARDCYP2D6
SCHEMBL6359444 0.87 PPARA (0.57) PPARAPPARGPPARDCYP2D6
SCHEMBL7596460 0.87 PPARA (0.58) PPARAPPARGPPARDCYP2D6
SCHEMBL6358170 0.84 PPARG (0.49) PPARAPPARGPPARDCYP2D6
SCHEMBL6363391 0.83 PPARA (0.60) PPARAPPARGPPARDCYP2D6
SCHEMBL6359939 0.83 PPARG (0.84) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004520397-A 2004-07-08 JP claimed
EP-1372632-A1 PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS Pfizer Products Inc. (US) 2004-01-02 EP claimed
US-20020169192-A1 PPAR compounds HAYWARD CHERYL M (US) 2002-11-14 US claimed
WO-2002064130-A1 PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS PFIZER PRODUCTS INC. (US) 2002-08-22 WO claimed
US-20050075377-A1 PPAR compounds PFIZER INC 2005-04-07 US disclosed
EP-1372632-A1 PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS Pfizer Products Inc. (US) 2004-01-02 EP disclosed
US-20020169192-A1 PPAR compounds HAYWARD CHERYL M (US) 2002-11-14 US disclosed
WO-2002064130-A1 PROLIFERATIVE ACTIVATOR RECEPTOR (PPAR) COMPOUNDS PFIZER PRODUCTS INC. (US) 2002-08-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020169192-A1 PPAR compounds PPARA, PPARG, PPARD PPARA 1/4885PPARG 2/4885PPARD 3/4885
US-20050075377-A1 PPAR compounds PPARA, PPARG, PPARD PPARA 1/4885PPARG 2/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.